Oral intake of AHCC(R)

3 trials

Sponsors

Taketomi Akinobu, Abe Takashige, Cho Yuko

Conditions

Childhood solid cancerhepatocellular carcinomaurothelial cancer

Phase 2

Pilot study for evaluation of the effect of AHCC(R) on reducing lenvatinib-related adverse events in patients.

RecruitingJPRN-jRCTs011230061

Taketomi Akinobuhepatocellular carcinoma

Start: 2024-05-13Target: 129Updated: 2026-06-29

A clinical study to evaluate the efficacy of AHCC(R) in reducing bone marrow suppression caused by chemotherapy for urothelial carcinoma.

RecruitingJPRN-jRCTs011240005

Abe Takashigeurothelial cancer

Start: 2024-05-01Target: 94Updated: 2026-06-29

Clinical study for investigation of immunostimulatory effect of AHCC(R) on pediatric cancer patients

RecruitingJPRN-jRCTs011240079

Cho YukoChildhood solid cancer

Start: 2025-09-26Target: 20Updated: 2026-06-29